Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 13,521,000 | 13,154,000 | 11,402,000 | 10,627,000 | 9,179,000 |
Cost of Goods | 3,873,000 | 3,450,000 | 3,104,000 | 3,199,000 | 4,546,000 |
Gross Profit | 9,648,000 | 9,704,000 | 8,298,000 | 7,428,000 | 4,633,000 |
Operating Expenses | 5,897,000 | 4,781,000 | 6,602,000 | 4,599,000 | 8,009,000 |
Operating Income | 3,751,000 | 4,923,000 | 1,696,000 | 2,829,000 | -3,376,000 |
Other Income | 158,000 | 343,000 | 21,000 | 158,000 | -46,000 |
Pre-tax Income | 3,909,000 | 5,266,000 | 1,717,000 | 2,987,000 | -3,422,000 |
Income Tax | 85,000 | 695,000 | 503,000 | 238,000 | -55,000 |
Net Income Continuous | 3,824,000 | 4,571,000 | 1,214,000 | 2,749,000 | -3,367,000 |
Net Income Discontinuous | 372,000 | N/A | 332,000 | N/A | 1,270,000 |
Minority Interests | 438,000 | 4,000 | 1,000 | -430,000 | -2,000 |
Net Income | $3,758,000 | $4,567,000 | $1,545,000 | $3,179,000 | $-2,095,000 |
EPS Basic Total Ops | 1.48 | 1.81 | 0.61 | 1.26 | -0.83 |
EPS Basic Continuous Ops | 1.51 | 1.81 | 0.48 | 1.08 | -1.33 |
EPS Basic Discontinuous Ops | -0.02 | N/A | 0.13 | 0.17 | 0.51 |
EPS Diluted Total Ops | 1.48 | 1.80 | 0.61 | 1.25 | -0.82 |
EPS Diluted Continuous Ops | 1.50 | 1.80 | 0.48 | 1.08 | -1.32 |
EPS Diluted Discontinuous Ops | -0.02 | N/A | 0.13 | 0.17 | 0.50 |
EBITDA(a) | $4,586,000 | $5,682,000 | $2,424,000 | $3,721,000 | $-2,493,000 |